Víctor Albarrán Fernández
Medical Oncologist & Researcher, Cell Therapy for Solid Tumors FCRB-IDIBAPS
Seminars
Thursday 19th November 2026
Advancing Clinical Decision Making by Reverse Translating Tumor & T-Cell Biomarker Signals Into Actionable TIL Response Frameworks
11:15 am
- Leveraging PD-1-positive TIL selection strategies as surrogate biomarkers of tumor reactivity in breast cancer solid tumor
- Correlating TCR clonal expansion dynamics with multiomic translational datasets to identify predictive biomarkers of response
- Building translational workflows to integrate TCR sequencing, tumor biology, and patient response data for next-generation TIL and TCR-T development
